Cunningham Everett

Avg. Two Year Performance

No purchase track record
(12%) Avg. Sale Return
(6%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%(2%)13%(12%)(12%)
Sale Success Rate1 of 31 of 31 of 31 of 30 of 3
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 18.65K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Health Services » Medical Laboratories & Research

SVP, Commercial:

Holdings: 39.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--